Top Tweets for #nouscom
Nouscom has raised €120m in Series D funding to advance NOUS-209, an experimental cancer immunotherapy for people with Lynch syndrome.
🔗 Full story: https://t.co/plXPjd3Br3
#Nouscom #CancerImmunotherapy #LynchSyndrome #BiotechFunding #CancerResearch
Neva Sgr, Angelini Industries e la Banca europea per gli investimenti partecipano al round Serie D da 120 milioni di euro per #Nouscom, biotech specializzata in immunoterapie innovative contro i tumori. Tutti i dettagli
https://t.co/HCbmepsUbI
Nouscom Shares Positive Final Phase Ib/II Results of NOUS-209 in Lynch Syndrome at AACR 2025, Demonstrating Lasting and Strong Immune Response - Check the Link for More https://t.co/3P6BwRwbVe #Nouscom #LynchSyndrome #RareDiseases #OrphanDrugs #AACR
Today's startup funding news:@onwdempowered raises €20M, @hemotune receives CHF 14M, #Nouscom extends Series C round to $82M, @venturekick supports 5 #startups with CHF10k each, and #Spirecut secures fresh #funding. https://t.co/dGdnlqfQ54
@RenoHemonc @EmilyHarrold6 @StadlerZsofia @MikeFooteMD @WeillCornell @mdmanishshah There are many in the pipeline. This is the most recent #vaccine that’s off the shelf for MSI-High specifically.
NOUS-209 with pembrolizumab.
#CRCSM #STCSM
“#Nouscom Begins Phase II Trial of Neoantigen-Targeted Cancer Vaccine With Checkpoint Inhibitor” https://t.co/2ADElAtN7o
New board members to accelerate growth @exnaton_tech #Anapaya #Vectivbio #Nouscom https://t.co/jTTCK1tVwi | The Swiss Startup News channel https://t.co/dCTiNKTvGR
Round da 42 milioni di euro per la #startup #biotech #Nouscom #Abingworth #5amVentures https://t.co/192gKylvqR
'Two years in, #NousCom bags $49m to fund first human studies of neoantigen drugs' -
via @endpts @JohnCendpts https://t.co/l4jfiD7S3l
#NousCom bags €42M to trial off-the-shelf #cancervaccine #VC $GSK #EU #biotech https://t.co/O6xPJCJf6l
Two years in, the team at #NousCom bags $49M to fund first human studies of #neoantigen drugs #biotech #EU #pharma https://t.co/JvebF8ZwQN
'Swiss Biotech #NousCom pulls major investors into €42M Series B for #cancer vaccines’ - via @Labiotech_eu https://t.co/V13KilyJe0
#Vaccine specialist #NousCom closed a €42m Series B financing round. New investors: @Abingworthbio, @5amVentures https://t.co/CFDCg8YOc3
42 Mio. Euro: #Nouscom zählt jetzt auch @Abingworthbio zu seinen Investoren #Krebs #Impfstoffe @LSP_PublicFund https://t.co/1aJEjq3Fq5
'Swiss Biotech #NousCom pulls major investors into €42M Series B for #cancer vaccines’ - via @Labiotech_eu https://t.co/V13KilyJe0
#Nouscom hires Marina Udier Blagovic as Chief Operating Officer
https://t.co/Tdg99uFj9j
Last Seen Hashtags on Sotwe
padreyhija
Seen from Mexico
khẩu dâm
Seen from Vietnam
minichatt
Seen from Mexico
抽逼
Seen from United States
minichat filter:videos
Seen from Belgium
minichatt ()()** filter:videos
Seen from Chile
wazazi
anxiouspanda()+filter:native_video
Seen from United States
meme ifşa
Seen from Turkey
menswaxing
Seen from Vietnam
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers